Corrigendum: Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

[This corrects the article DOI: 10.3389/fphar.2024.1381523.].

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 15; p. 1464358
Main Authors Aldossary, Khlood Mohammad, Saad Ali, Lashin, Abdallah, Mahmoud S, Bahaa, Mostafa M, Elmasry, Thanaa A, Elberri, Eman I, Kotkata, Fedaa A, El Sabaa, Ramy M, Elmorsi, Yasmine M, Kamel, Mostafa M, Negm, Walaa A, Elberri, Aya Ibrahim, Hamouda, Amir O, AlRasheed, Hayam Ali, Salahuddin, Muhammed M, Yasser, Mohamed, Hamouda, Manal A
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 29.08.2024
Subjects
atorvastatin
major depressive disorder
neuroinflammation
NLRP-3
Pharmacology
STAT-3
STAT-3
major depressive disorder
neuroinflammation
NLRP-3
atorvastatin
Online AccessGet full text

Cover

More Information
Summary:[This corrects the article DOI: 10.3389/fphar.2024.1381523.].
Bibliography:corrigendum
ObjectType-Correction/Retraction-1
content type line 23
SourceType-Scholarly Journals-1
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2024.1464358